Literature DB >> 12121655

Crystal structure of a human rhinovirus that displays part of the HIV-1 V3 loop and induces neutralizing antibodies against HIV-1.

Jianping Ding1, Allen D Smith, Sheila C Geisler, Xuejun Ma, Gail Ferstandig Arnold, Eddy Arnold.   

Abstract

We report the 2.7 A resolution structure of a chimeric rhinovirus, MN-III-2, that displays part of the HIV-1 gp120 V3 loop and elicits HIV-neutralizing antibodies. The V3 loop insert is dominated by two type I beta turns. The structures of two adjacent tripeptides resemble those of analogous segments in three Fab/V3 loop peptide complexes. Although two of the three corresponding antibodies bind and neutralize MN-III-2 well, only one of the three can bind without significant rearrangement. These results suggest that the V3 loop insert: (1) can share some local conformational similarity to V3 loop sequences presented on different structural frameworks; (2) must be able to adopt multiple conformations, even in a relatively constrained environment; and (3) may mimic the conformational variability of the epitope on HIV-1, increasing the likelihood of eliciting appropriate neutralizing immune responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121655     DOI: 10.1016/s0969-2126(02)00793-1

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  12 in total

1.  Structure of an antibody in complex with its mucin domain linear epitope that is protective against Ebola virus.

Authors:  Daniel Olal; Ana I Kuehne; Shridhar Bale; Peter Halfmann; Takao Hashiguchi; Marnie L Fusco; Jeffrey E Lee; Liam B King; Yoshihiro Kawaoka; John M Dye; Erica Ollmann Saphire
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

2.  Crystal Structure of the Conserved Amino Terminus of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus Gripped by an Antibody.

Authors:  Ki Joon Cho; Bert Schepens; Kristof Moonens; Lei Deng; Walter Fiers; Han Remaut; Xavier Saelens
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

3.  Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.

Authors:  Kausik Chakraborty; Venuka Durani; Edward Roshan Miranda; Michael Citron; Xiaoping Liang; William Schleif; Joseph G Joyce; Raghavan Varadarajan
Journal:  Biochem J       Date:  2006-11-01       Impact factor: 3.857

4.  Fold recognition of the human immunodeficiency virus type 1 V3 loop and flexibility of its crown structure during the course of adaptation to a host.

Authors:  Teruaki Watabe; Hirohisa Kishino; Yoshiyasu Okuhara; Yasuhiro Kitazoe
Journal:  Genetics       Date:  2005-12-15       Impact factor: 4.562

5.  An antibody to the putative aphid recognition site on cucumber mosaic virus recognizes pentons but not hexons.

Authors:  Valorie D Bowman; Elaine S Chase; Alexander W E Franz; Paul R Chipman; Xing Zhang; Keith L Perry; Timothy S Baker; Thomas J Smith
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFNγ production by CD4+ T cells.

Authors:  Antonella Caivano; Nicole A Doria-Rose; Benjamin Buelow; Rossella Sartorius; Maria Trovato; Luciana D'Apice; Gonzalo J Domingo; William F Sutton; Nancy L Haigwood; Piergiuseppe De Berardinis
Journal:  Virology       Date:  2010-09-20       Impact factor: 3.616

7.  Crystal structures of enterovirus 71 (EV71) recombinant virus particles provide insights into vaccine design.

Authors:  Ke Lyu; Guang-Chuan Wang; Ya-Ling He; Jian-Feng Han; Qing Ye; Cheng-Feng Qin; Rong Chen
Journal:  J Biol Chem       Date:  2014-12-09       Impact factor: 5.157

8.  Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds.

Authors:  Ying Zhang; Alan A Simpson; Rebecca M Ledford; Carol M Bator; Sugoto Chakravarty; Gregory A Skochko; Tina M Demenczuk; Adiba Watanyar; Daniel C Pevear; Michael G Rossmann
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Pocket factors are unlikely to play a major role in the life cycle of human rhinovirus.

Authors:  Umesh Katpally; Thomas J Smith
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

10.  In silico vaccine design based on molecular simulations of rhinovirus chimeras presenting HIV-1 gp41 epitopes.

Authors:  Mauro Lapelosa; Emilio Gallicchio; Gail Ferstandig Arnold; Eddy Arnold; Ronald M Levy
Journal:  J Mol Biol       Date:  2008-11-08       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.